733.50
+2.85%
Close of 9 Nov 2026, in INR
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Aster DM Healthcare
Its shares trade on NSE under the ticker ASTERDM.NS. It has been listed since 26 February 2018. In the fiscal year to 31 March 2026, it reported revenue of ₹46.43bn and net income of ₹3.88bn. At that date it held total assets of ₹81.12bn and shareholders' equity of ₹45.76bn.
Aster DM Healthcare Ltd. engages in the provision of healthcare solutions. The company is headquartered in Bangalore, Karnataka. The company went IPO on 2018-02-26. The Company’s segments include Hospitals, Clinics, Retail Pharmacies and Others. The Hospitals segment comprises of hospitals and in-house pharmacies at the hospitals. The Clinics segment comprises of clinics and in-house pharmacies at the clinics. The Retail Pharmacies segment comprises standalone retail pharmacies and optical outlets. The Other segment comprises healthcare consultancy services. Its geographical segments consist of gulf corporation council (GCC) States, including United Arab Emirates, Qatar, Oman, Kingdom of Saudi Arabia, Jordan, Kuwait, Bahrain, and India. The firm's healthcare services are offered under Aster, Medcare and Access brands. The company operates over 33 hospitals, 127 clinics, 527 pharmacies (Including 255 Pharmacies in India operated by Alfaone Retail Pharmacies Private Limited under brand license from Aster), and 229 labs and patient experience centers in seven countries, including India.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- Listed since
- 26 Feb 2018
- Employees
- 24,653
- Website
- asterdmhealthcare.com ↗
Leadership
Pay as last reported
- Dr. Mandayapurath Azad MoopenExecutive Chairman of the Board, Managing Director, since 2008₹95.0m
- Mr. Sunil KumarChief Financial Officer
- Mr. Hemish PurushottamCompliance Officer, Company Secretary₹2.8m
- Ms. Alisha MoopenDeputy Managing Director, Executive Director, since 2013₹3.0m
- Mr. Shamsudheen Bin Mohideen Mammu HajiNon-Executive Director
- Dr. Zeba MoopenNon-Executive Director
- Mr. Thadathil WilsonNon-Executive Director₹8.3m
- Ms. Purana DeeptiNon-Executive Independent Director₹3.8m
- Mr. Chenayappillil GeorgeNon-Executive Independent Director₹2.0m
- Dr. James MathewNon-Executive Independent Director₹4.6m
- Shri. Maniedath NambiarNon-Executive Independent Director, since 2024₹1.5m
- Mr. Sunil VasudevanNon-Executive Independent Director₹1.7m
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Aster DM Healthcare operates 33 hospitals across seven countries including India.
- Aster DM Healthcare manages 127 clinics and 527 pharmacies under Aster, Medcare, and Access brands.
- Aster DM Healthcare employs 24,653 full-time employees providing healthcare solutions in GCC and India.
Weaknesses
- Aster DM Healthcare's retail pharmacies include 255 locations in India operated by Alfaone Retail Pharmacies Private Limited.
- Aster DM Healthcare's geographical presence is limited to GCC States and India with no operations in other regions.
- Aster DM Healthcare's business segments include Hospitals, Clinics, Retail Pharmacies, and Others with no expansion into new sectors.
Opportunities
- Aster DM Healthcare can expand its retail pharmacy presence in India beyond the current 255 locations.
- Aster DM Healthcare can leverage its 229 labs and patient experience centers for telemedicine services.
- Aster DM Healthcare can increase its hospital operations in the GCC States beyond the current 33 hospitals.
Threats
- Aster DM Healthcare faces competition from local healthcare providers in the GCC States and India.
- Aster DM Healthcare must comply with healthcare regulations in seven countries including India and GCC States.
- Aster DM Healthcare's reliance on the GCC States and India for revenue poses a risk if these markets decline.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.